These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 993345)

  • 1. Pathogenesis and characterization of hyperglucagonemia in the uremic rat.
    Emmanouel DS; Jaspan JB; Kuku SF; Rubenstein AH; Katz AI; Huen AH
    J Clin Invest; 1976 Nov; 58(5):1266-72. PubMed ID: 993345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of plasma glucagon. Circulating components in normal subjects and patients with chronic renal failure.
    Kuku SF; Jaspan JB; Emmanouel DS; Zeidler A; Katz AI; Rubenstein AH
    J Clin Invest; 1976 Sep; 58(3):742-50. PubMed ID: 956399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucagon metabolism in the rat.
    Emmanouel DS; Jaspan JB; Rubenstein AH; Huen AH; Fink E; Katz AI
    J Clin Invest; 1978 Jul; 62(1):6-13. PubMed ID: 659638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the liver in glucagon metabolism.
    Jaspan JB; Huen AH; Morley CG; Moossa AR; Rubenstein AH
    J Clin Invest; 1977 Aug; 60(2):421-8. PubMed ID: 874100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon and insulin binding to liver membranes in a partially nephrectomized uremic rat model.
    Soman V; Felig P
    J Clin Invest; 1977 Jul; 60(1):224-32. PubMed ID: 326810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of hyperprolactinemia in uremic rats.
    Martín-Oar JE; Peces R; Ramos B; López-Novoa JM; Hernando L
    Endocrinology; 1981 Jun; 108(6):2283-6. PubMed ID: 7227307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperglucagonemia of renal failure.
    Bilbrey GL; Faloona GR; White MG; Knochel JP
    J Clin Invest; 1974 Mar; 53(3):841-7. PubMed ID: 4812442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential immunoreactivity of plasma glucagon components in man: studies with different glucagon antibodies.
    Soybel D; Jaspan J; Polonsky K; Goldberg I; Rayfield E; Tager H
    J Clin Endocrinol Metab; 1983 Mar; 56(3):612-8. PubMed ID: 6185527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma glucagon and insulin in rat pregnancy. Roles in glucose homeostasis.
    Saudek CD; Finkowski M; Knopp RH
    J Clin Invest; 1975 Jan; 55(1):180-7. PubMed ID: 1109177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A re-evaluation of the renal ablation model of progressive renal disease in rats.
    Kim KH; Kim Y; Park HW; Jeong HJ; Mauer M
    J Nephrol; 2003; 16(2):196-202. PubMed ID: 12768066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive renal insufficiency induces increasing protection against ischemic acute renal failure.
    Zager RA; Baltes LA
    J Lab Clin Med; 1984 Apr; 103(4):511-23. PubMed ID: 6699471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancy of fasting plasma glucagon levels measured by different glucagon antisera.
    Tahara Y; Tanaka A; Yamamoto Y; Fukuda M; Kumahara Y; Shima K
    Diabetes Res; 1988 Apr; 7(4):179-83. PubMed ID: 3402167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of kidney failure with fetal kidney precursor cell transplantation.
    Kim SS; Park HJ; Han J; Gwak SJ; Park MH; Song KW; Rhee YH; Min Chung H; Kim BS
    Transplantation; 2007 May; 83(9):1249-58. PubMed ID: 17496543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the control of sodium excretion in experimental uremia.
    Schultze RG; Shapiro HS; Bricker NS
    J Clin Invest; 1969 May; 48(5):869-77. PubMed ID: 5780197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ammonium chloride and dietary phosphorus in the azotaemic rat. I. Renal function and biochemical changes.
    Jara A; Chacón C; Ibaceta M; Valdivieso A; Felsenfeld AJ
    Nephrol Dial Transplant; 2004 Aug; 19(8):1986-92. PubMed ID: 15173378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucagon deficiency and hyperaminoacidemia after total pancreatectomy.
    Boden G; Master RW; Rezvani I; Palmer JP; Lobe TE; Owen OE
    J Clin Invest; 1980 Mar; 65(3):706-16. PubMed ID: 6986412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglucagonemia following cisplatin treatment.
    Goldstein RS; Mayor GH; Gingerich RL; Hook JB; Robinson B; Bond JT
    Toxicol Appl Pharmacol; 1983 Apr; 68(2):250-9. PubMed ID: 6683010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute uremia following dietary potassium depletion. I. Effect on blood parameters related to carbohydrate metabolism.
    Hörl WH; Schaefer RM; Haag M; Heidland A
    Miner Electrolyte Metab; 1986; 12(4):218-25. PubMed ID: 3762508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.